Literature DB >> 22737557

Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran.

M Metanat1, B Sharifi-Mood, Sh Shahreki, S H Dawoudi.   

Abstract

Entities:  

Keywords:  Extensively drug-resistant; Multidrug-resistant; Pulmonary; Tuberculosis

Year:  2012        PMID： 22737557      PMCID： PMC3372018     

Source DB:  PubMed          Journal:  Iran Red Crescent Med J        ISSN： 2074-1804            Impact factor:   0.611


× No keyword cloud information.
  13 in total

Review 1.  Drug-resistant and multidrug-resistant tubercle bacilli.

Authors:  B Petrini; S Hoffner
Journal:  Int J Antimicrob Agents       Date:  1999-10       Impact factor: 5.283

2.  Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran.

Authors:  Mohamad Reza Masjedi; Parissa Farnia; Setara Sorooch; Majid Valiollah Pooramiri; Seyed Davood Mansoori; Abolhasan Zia Zarifi; Ali Akbarvelayati; Sven Hoffner
Journal:  Clin Infect Dis       Date:  2006-08-21       Impact factor: 9.079

3.  Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

Authors:  O S Toungoussova; A O Mariandyshev; G Bjune; D A Caugant; P Sandven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

4.  Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.

Authors:  Seyed Mehdi Mirsaeidi; Payam Tabarsi; Kaveh Khoshnood; Majid Valiollah Pooramiri; Ali Rowhani-Rahbar; Seyed Davood Mansoori; Heydar Masjedi; Soheyla Zahirifard; Foroozan Mohammadi; Parisa Farnia; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  Int J Infect Dis       Date:  2005-09-23       Impact factor: 3.623

5.  Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-11-10

6.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa.

Authors:  Neel R Gandhi; Anthony Moll; A Willem Sturm; Robert Pawinski; Thiloshini Govender; Umesh Lalloo; Kimberly Zeller; Jason Andrews; Gerald Friedland
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

7.  First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Authors:  Masoud Shamaei; Majid Marjani; Ehsan Chitsaz; Mehdi Kazempour; Mehdi Esmaeili; Parisa Farnia; Payam Tabarsi; Majid V Amiri; Mehdi Mirsaeidi; Davood Mansouri; Mohammad R Masjedi; Ali A Velayati
Journal:  Int J Infect Dis       Date:  2009-03-13       Impact factor: 3.623

8.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Authors:  A Pablos-Méndez; M C Raviglione; A Laszlo; N Binkin; H L Rieder; F Bustreo; D L Cohn; C S Lambregts-van Weezenbeek; S J Kim; P Chaulet; P Nunn
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

9.  Extensively drug-resistant tuberculosis in california, 1993-2006.

Authors:  Ritu Banerjee; Jennifer Allen; Janice Westenhouse; Peter Oh; William Elms; Ed Desmond; Annette Nitta; Sarah Royce; Jennifer Flood
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

10.  Worldwide emergence of extensively drug-resistant tuberculosis.

Authors:  N Sarita Shah; Abigail Wright; Gill-Han Bai; Lucia Barrera; Fadila Boulahbal; Nuria Martín-Casabona; Francis Drobniewski; Chris Gilpin; Marta Havelková; Rosario Lepe; Richard Lumb; Beverly Metchock; Françoise Portaels; Maria Filomena Rodrigues; Sabine Rüsch-Gerdes; Armand Van Deun; Veronique Vincent; Kayla Laserson; Charles Wells; J Peter Cegielski
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
View more
  7 in total

1.  Prevalence and Determinants of Multidrug-Resistant Tuberculosis in Makkah, Saudi Arabia.

Authors:  Mohammad Fouad Mohammad Khatib Sambas; Unaib Rabbani; Manal Mansour Mezal Al-Gethamy; Saud Hasan Surbaya; Faisal Fuwaran Irmat Alharbi; Riyadh Ghazi Abdulrahman Ahmad; Hamzah Khalid Hamzah Qul; Safa Mohammed Saeed Nassar; Abdulaziz Khalid Mohammed Ali Maddah; Basel Ali Kabah Darweesh
Journal:  Infect Drug Resist       Date:  2020-11-10       Impact factor: 4.003

2.  Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar.

Authors:  Sunita Tripathy; Rajesh Kumar; Surya Deo Singh
Journal:  J Clin Diagn Res       Date:  2015-11-01

3.  Epidemiological Characterization of Drug Resistance among Mycobacterium tuberculosis Isolated from Patients in Northeast of Iran during 2012-2013.

Authors:  Ashraf Tavanaee Sani; Abolfazl Shakiba; Maryam Salehi; Hamid Reza Bahrami Taghanaki; Seiedeh Fatemeh Ayati Fard; Kiarash Ghazvini
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

Review 4.  Emerging and re-emerging infectious diseases in Iran.

Authors:  Najmeh Parhizgari; Mohammad Mehdi Gouya; Ehsan Mostafavi
Journal:  Iran J Microbiol       Date:  2017-06

5.  Low Levels of Extensively Drug-resistant Tuberculosis among Multidrug Resistant Tuberculosis Isolates and Their Relationship to Risk Factors: Surveillance in Tehran, Iran; 2006 to 2014.

Authors:  Alireza Hadizadeh Tasbiti; Shamsi Yari; Mostafa Ghanei; Mohammad Ali Shokrgozar; Abolfazl Fateh; Ahmadreza Bahrmand
Journal:  Osong Public Health Res Perspect       Date:  2017-04-30

6.  Determining the Risk of Intra-Community Transmission of Tuberculosis in the Northwest of Iran Through 15 Loci Miru-Vntr Typing.

Authors:  Ali Afaghi-Gharamaleki; Seyyedreza Moaddab; Mojtaba Darbouy; Khalil Ansarin; Shahram Hanifian
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-02-27

7.  Prevalence and Factors Associated with Multidrug-Resistant Tuberculosis (MDR-TB) among Presumptive MDR-TB Patients in Tigray Region, Northern Ethiopia.

Authors:  Kibriti Mehari; Tsehaye Asmelash; Haftamu Hailekiros; Tewolde Wubayehu; Hagos Godefay; Tadele Araya; Muthupandian Saravanan
Journal:  Can J Infect Dis Med Microbiol       Date:  2019-09-09       Impact factor: 2.471
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.